Siegfried Holding AGXSWX:SFZN -2.98%96 Current Ratio is 2.00 as of Dec. 2025, which is 35% below its 10-year median of 3.06. GuruFocus rates XSWX:SFZN with a GF Score™ of 96/100 and a GF Value™ of CHF91.96 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 995 Drug Manufacturers companies, Siegfried Holding AG ranks better than 50.45% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Siegfried Holding AG's current ratio for the quarter that ended in Dec. 2025 was 2.00.
Siegfried Holding AG has a current ratio of 2.00. It generally indicates good short-term financial strength.
The historical rank and industry rank for Siegfried Holding AG's Current Ratio or its related term are showing as below:
XSWX:SFZN'
s Current Ratio Range Over the Past 10 Years
Min: 1.96 Med: 3.06 Max: 3.79
Current: 2
During the past 13 years, Siegfried Holding AG's highest Current Ratio was 3.79. The lowest was 1.96. And the median was 3.06.
XSWX:SFZN's Current Ratio is ranked better than 50.45% of 995
companies
in the Drug Manufacturers industry
Industry Median: 2
vs XSWX:SFZN: 2.00
Siegfried Holding AG (XSWX:SFZN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Siegfried Holding AG Current Ratio Related Terms
Siegfried Holding AG Current Ratio Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SFZN vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) has a Current Ratio of 2.00 as of Dec. 2025. This is 35% below median its historical median of 3.06. Over the past decade, Siegfried Holding AG's Current Ratio has ranged from 1.96 to 3.79. According to the industry distribution chart, Siegfried Holding AG ranks #493 out of 995 companies in the Drug Manufacturers industry, placing it in the top 49.5%.
Is Siegfried Holding AG's Current Ratio too high?
Siegfried Holding AG's current Current Ratio of 2.00 is 35% below median its 10-year median of 3.06. Over the past 10 years, this metric has ranged from a low of 1.96 to a high of 3.79. The Drug Manufacturers industry median Current Ratio is 2.00. Siegfried Holding AG's value of 2.00 is 0% at this industry median. Based on the distribution chart, Siegfried Holding AG ranks #493 out of 995 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #493 out of 995 companies for Current Ratio. This puts Siegfried Holding AG in the upper half of its industry. The industry median Current Ratio is 2.00. Siegfried Holding AG's value of 2.00 is 0% at this benchmark. Historically, Siegfried Holding AG's own Current Ratio has ranged from 1.96 to 3.79 over the past decade. While the company's 10-year median is 3.06 vs. the industry median of 2.00, Siegfried Holding AG has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current Current Ratio of 2.00 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current Current Ratio is 2.00, which is 35% below median its own 10-year median of 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF91.96, compared to a current price of CHF70.00 — trading 23.9% below its estimated fair value. The current Current Ratio is 2.00, which is 35% below median its 10-year median of 3.06 and 0% at the Drug Manufacturers industry median of 2.00. Siegfried Holding AG's overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Current Ratio is 2.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF70.00 is trading 23.9% below its estimated GF Value™ of CHF91.96.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
Current Ratio: 2.00 (35% below median its 10-year median of 3.06)
GF Value™: CHF91.96 vs. price of CHF70.00 (23.9% below fair value)
Industry Position: 0% at the Drug Manufacturers median (#493 of 995)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
96GF Score
Get the complete analysis for XSWX:SFZN
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
